AQR Capital Management LLC Grows Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

AQR Capital Management LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 382.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,363 shares of the biotechnology company's stock after purchasing an additional 18,518 shares during the period. AQR Capital Management LLC's holdings in Axon Enterprise were worth $13,885,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the fourth quarter worth about $45,000. Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at about $53,000. GPS Wealth Strategies Group LLC grew its position in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after buying an additional 40 shares during the last quarter. Finally, Versant Capital Management Inc raised its stake in shares of Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after acquiring an additional 95 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Price Performance

Shares of AXON traded down $2.24 during trading hours on Friday, hitting $684.59. 642,401 shares of the stock were exchanged, compared to its average volume of 764,683. The stock's 50-day moving average price is $561.38 and its two-hundred day moving average price is $582.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $53.29 billion, a price-to-earnings ratio of 176.90, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.15 EPS. Research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on AXON. The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC lifted their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday. Barclays upped their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday. Finally, Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $640.91.

Insiders Place Their Bets

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.